Grover’s-like drug eruption in a patient with metastatic melanoma under ipilimumab therapy

BACKGROUND: Dermatologic toxicity is an important adverse effect of immune checkpoint inhibitors targeting cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and programmed cell death 1 receptor (PD-1) or PD ligand 1 (PD-L1). Skin toxicity most commonly includes a maculopapular erythematous rash a...

Descripción completa

Detalles Bibliográficos
Autores principales: Koelzer, Viktor H., Buser, Tobias, Willi, Niels, Rothschild, Sacha I., Wicki, Andreas, Schiller, Peter, Cathomas, Gieri, Zippelius, Alfred, Mertz, Kirsten D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986338/
https://www.ncbi.nlm.nih.gov/pubmed/27532022
http://dx.doi.org/10.1186/s40425-016-0151-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986338/
https://www.ncbi.nlm.nih.gov/pubmed/27532022
http://dx.doi.org/10.1186/s40425-016-0151-z

Ejemplares similares